Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 509

1.

Age-related neurodegenerative diseases.

Duggan M, Torkzaban B, Ahooyi TM, Khalili K, Gordon J.

J Cell Physiol. 2019 Sep 25. doi: 10.1002/jcp.29248. [Epub ahead of print] Review.

PMID:
31556109
2.

Author response: Comment and questions to Mottola et al (2018): 2018 Canadian guideline for physical activity throughout pregnancy.

Davenport MH, Mottola MF, Ruchat SM, Davies GA, Poitras VJ, Gray CE, Jaramillo Garcia A, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal TS, Slater LG, Stirling D, Zehr L.

J Obstet Gynaecol Can. 2019 Oct;41(10):1406-1408. doi: 10.1016/j.jogc.2019.04.022. No abstract available.

PMID:
31548038
3.

Feasibility of a Portable Abdominal Insufflation Device for Controlling Intraperitoneal Bleeding After Abdominal Blunt Trauma.

Gruionu G, Gruionu LG, Duggan M, Surlin V, Patrascu S, Velmahos G.

Surg Innov. 2019 Aug 16:1553350619869057. doi: 10.1177/1553350619869057. [Epub ahead of print]

PMID:
31418332
4.

Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol.

Samimi G, Trabert B, Geczik AM, Duggan MA, Sherman ME.

JNCI Cancer Spectr. 2018 Dec 14;2(4):pky061. doi: 10.1093/jncics/pky061. eCollection 2018 Oct.

5.

Assessment of Walking Routes as a Possible Approach for Promoting Physical Activity in Children with Autism Spectrum Disorder: Brief Report.

Oreskovic NM, Neumeyer AM, Duggan MP, Kuhlthau KA.

Dev Neurorehabil. 2019 Jul 25:1-5. doi: 10.1080/17518423.2019.1646343. [Epub ahead of print]

PMID:
31342814
6.

An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.

Pinette A, McMichael E, Courtney NB, Duggan M, Benner BN, Choueiry F, Yu L, Abood D, Mace TA, Carson WE 3rd.

Cancer Immunol Immunother. 2019 Aug;68(8):1379-1389. doi: 10.1007/s00262-019-02372-2. Epub 2019 Jul 23.

PMID:
31338557
7.

SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M4 PAMs.

Chopko TC, Han C, Gregro AR, Engers DW, Felts AS, Poslusney MS, Bollinger KA, Morrison RD, Bubser M, Lamsal A, Luscombe VB, Cho HP, Schnetz-Boutaud NC, Rodriguez AL, Chang S, Daniels JS, Stec DF, Niswender CM, Jones CK, Wood MR, Wood MW, Duggan ME, Brandon NJ, Conn PJ, Bridges TM, Lindsley CW, Melancon BJ.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2224-2228. doi: 10.1016/j.bmcl.2019.06.032. Epub 2019 Jun 20.

PMID:
31248774
8.

Post-colposcopy Management of ASC-US and LSIL Pap Tests (PALS Trial): Pilot RCT.

Saciragic L, Nelson G, Chiarella-Redfern H, Kanarek N, Nation J, Duggan MA.

J Obstet Gynaecol Can. 2019 Jul;41(7):916-925. doi: 10.1016/j.jogc.2018.08.004. Epub 2018 Oct 27.

PMID:
31230661
9.

Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Laws A, Hughes ME, Hu J, Barry WT, Dominici L, Nakhlis F, Barbie T, Duggan M, Weiss A, Rhei E, Carter K, Nimbkar S, Schnitt SJ, King TA.

Ann Surg Oncol. 2019 Nov;26(12):3846-3855. doi: 10.1245/s10434-019-07515-4. Epub 2019 Jun 20.

PMID:
31222687
10.

Transcriptomic changes in the prefrontal cortex of rats as a function of age and cognitive engagement.

Duggan MR, Joshi S, Tan YF, Slifker M, Ross EA, Wimmer M, Parikh V.

Neurobiol Learn Mem. 2019 Sep;163:107035. doi: 10.1016/j.nlm.2019.107035. Epub 2019 Jun 8.

PMID:
31185277
11.

A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.

McMichael EL, Benner B, Atwal LS, Courtney NB, Mo X, Davis ME, Campbell AR, Duggan MC, Williams K, Martin K, Levine K, Olaverria Salavaggione GN, Noel T, Ganju A, Uppati S, Paul B, Olencki T, Teknos TN, Savvides P, Tridandapani S, Byrd JC, Caligiuri MA, Liu SV, Carson WE 3rd.

Clin Cancer Res. 2019 Aug 15;25(16):4955-4965. doi: 10.1158/1078-0432.CCR-18-2108. Epub 2019 May 29.

PMID:
31142501
12.

Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.

Benner B, Scarberry L, Suarez-Kelly LP, Duggan MC, Campbell AR, Smith E, Lapurga G, Jiang K, Butchar JP, Tridandapani S, Howard JH, Baiocchi RA, Mace TA, Carson WE 3rd.

J Immunother Cancer. 2019 May 28;7(1):140. doi: 10.1186/s40425-019-0622-0.

13.

Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.

Duggan MC, Regan-Fendt K, Olaverria Salavaggione GN, Howard JH, Stiff AR, Sabella J, Latchana N, Markowitz J, Gru A, Tridandapani S, Eisfeld AK, de la Chapelle A, Carson WE.

Melanoma Res. 2019 Oct;29(5):491-500. doi: 10.1097/CMR.0000000000000623.

PMID:
31116161
14.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.

Taylor SA, Mallett S, Ball S, Beare S, Bhatnagar G, Bhowmik A, Boavida P, Bridgewater J, Clarke CS, Duggan M, Ellis S, Glynne-Jones R, Goh V, Groves AM, Hameeduddin A, Janes SM, Johnston EW, Koh DM, Lock S, Miles A, Morris S, Morton A, Navani N, Oliver A, O'Shaughnessy T, Padhani AR, Prezzi D, Punwani S, Quinn L, Rafiee H, Reczko K, Rockall AG, Russell P, Sidhu HS, Strickland N, Tarver K, Teague J, Halligan S; Streamline investigators.

Lancet Respir Med. 2019 Jun;7(6):523-532. doi: 10.1016/S2213-2600(19)30090-6. Epub 2019 May 9.

15.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.

Taylor SA, Mallett S, Beare S, Bhatnagar G, Blunt D, Boavida P, Bridgewater J, Clarke CS, Duggan M, Ellis S, Glynne-Jones R, Goh V, Groves AM, Hameeduddin A, Janes SM, Johnston EW, Koh DM, Miles A, Morris S, Morton A, Navani N, O'Donohue J, Oliver A, Padhani AR, Pardoe H, Patel U, Punwani S, Quinn L, Rafiee H, Reczko K, Rockall AG, Shahabuddin K, Sidhu HS, Teague J, Thaha MA, Train M, van Ree K, Wijeyekoon S, Halligan S; Streamline investigators.

Lancet Gastroenterol Hepatol. 2019 Jul;4(7):529-537. doi: 10.1016/S2468-1253(19)30056-1. Epub 2019 May 9.

16.

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL.

Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24.

PMID:
31019022
17.

FIGO Stage Is the Strongest Prognostic Factor in Adenocarcinoma of the Uterine Cervix.

Glaze S, Duan Q, Sar A, Lee S, Köbel M, Park E, Duggan MA.

J Obstet Gynaecol Can. 2019 Sep;41(9):1318-1324. doi: 10.1016/j.jogc.2019.01.026. Epub 2019 Apr 19.

PMID:
31006541
18.

Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.

Regan-Fendt KE, Xu J, DiVincenzo M, Duggan MC, Shakya R, Na R, Carson WE 3rd, Payne PRO, Li F.

NPJ Syst Biol Appl. 2019 Feb 26;5:6. doi: 10.1038/s41540-019-0085-4. eCollection 2019.

19.

Corneal Higher-Order Aberrations in Descemet Membrane Endothelial Keratoplasty versus Ultrathin DSAEK in the Descemet Endothelial Thickness Comparison Trial: A Randomized Clinical Trial.

Duggan MJ, Rose-Nussbaumer J, Lin CC, Austin A, Labadzinzki PC, Chamberlain WD.

Ophthalmology. 2019 Jul;126(7):946-957. doi: 10.1016/j.ophtha.2019.02.007. Epub 2019 Feb 16.

PMID:
30776384
20.

Emergency cricothyroidotomy: an observational study to estimate optimal incision position and length.

Fennessy P, Drew T, Husarova V, Duggan M, McCaul CL.

Br J Anaesth. 2019 Feb;122(2):263-268. doi: 10.1016/j.bja.2018.10.003. Epub 2018 Nov 15.

PMID:
30686312
21.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S93-S113. doi: 10.1097/PGP.0000000000000524.

22.

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

Malpica A, Euscher ED, Hecht JL, Ali-Fehmi R, Quick CM, Singh N, Horn LC, Alvarado-Cabrero I, Matias-Guiu X, Hirschowitz L, Duggan M, Ordi J, Parkash V, Mikami Y, Ruhul Quddus M, Zaino R, Staebler A, Zaloudek C, McCluggage WG, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S9-S24. doi: 10.1097/PGP.0000000000000552.

23.

Presence of Small Screens in Bedrooms Is Associated With Shorter Sleep Duration and Later Bedtimes in Children With Obesity.

Duggan MP, Taveras EM, Gerber MW, Horan CM, Oreskovic NM.

Acad Pediatr. 2019 Jul;19(5):515-519. doi: 10.1016/j.acap.2018.11.004. Epub 2018 Nov 8.

PMID:
30415077
24.

The Impact of Gynaecological Tumour Board Rounds on Patient Care.

Halliday DA, Warfa K, Duggan MA, Nation J, Chu P, Nelson G, Glaze S, Mateshaytis J, Ghatage P.

J Obstet Gynaecol Can. 2019 Feb;41(2):180-184.e1. doi: 10.1016/j.jogc.2018.05.026. Epub 2018 Nov 2.

PMID:
30393059
25.

Theoretical optimal cricothyroidotomy incision length in female subjects, following identification of the cricothyroid membrane by digital palpation.

Fennessy P, Aslani A, Campbell M, Husarova V, Duggan M, McCaul CL.

Int J Obstet Anesth. 2018 Nov;36:42-48. doi: 10.1016/j.ijoa.2018.06.003. Epub 2018 Jun 30.

PMID:
30392652
26.

Deficits in Self-Reported Initiation Are AssociatedWith Subsequent Disability in ICU Survivors.

Wilson JE, Duggan MC, Chandrasekhar R, Brummel NE, Dittus RS, Ely EW, Patel MB, Jackson JC.

Psychosomatics. 2019 Jul - Aug;60(4):376-384. doi: 10.1016/j.psym.2018.09.004. Epub 2018 Sep 29.

PMID:
30352696
27.

N° 367-2019 Lignes Directrices Canadiennes Sur L'activité Physique Durant La Grossesse.

Mottola MF, Davenport MH, Ruchat SM, Davies GA, Poitras V, Gray C, Jaramillo Garcia A, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal T, Slater L, Stirling D, Zehr L.

J Obstet Gynaecol Can. 2018 Nov;40(11):1538-1548. doi: 10.1016/j.jogc.2018.09.003. Epub 2018 Oct 18. Erratum in: J Obstet Gynaecol Can. 2019 Jul;41(7):1068.

PMID:
30343980
28.

2019 Canadian Guideline for Physical Activity Throughout Pregnancy: Methodology.

Davenport MH, Ruchat SM, Mottola MF, Davies GA, Poitras VJ, Gray CE, Garcia AJ, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal T, Slater LG, Stirling D, Zehr L.

J Obstet Gynaecol Can. 2018 Nov;40(11):1468-1483. doi: 10.1016/j.jogc.2018.09.004. Epub 2018 Oct 18. No abstract available.

PMID:
30343979
29.

2019 Canadian guideline for physical activity throughout pregnancy.

Mottola MF, Davenport MH, Ruchat SM, Davies GA, Poitras VJ, Gray CE, Jaramillo Garcia A, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal T, Slater LG, Stirling D, Zehr L.

Br J Sports Med. 2018 Nov;52(21):1339-1346. doi: 10.1136/bjsports-2018-100056.

PMID:
30337460
30.

No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.

Mottola MF, Davenport MH, Ruchat SM, Davies GA, Poitras V, Gray C, Jaramillo Garcia A, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal T, Slater L, Stirling D, Zehr L.

J Obstet Gynaecol Can. 2018 Nov;40(11):1528-1537. doi: 10.1016/j.jogc.2018.07.001. Epub 2018 Oct 5. Erratum in: J Obstet Gynaecol Can. 2019 Jul;41(7):1067.

PMID:
30297272
31.

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC).

Glynne-Jones R, Hall MR, Lopes A, Pearce S, Goh V, Bosompem S, Bridgewater J, Chau I, Wasan H, Moran B, Melcher L, West NP, Quirke P, Wong WL, Beare S, Hava N, Duggan M, Harrison M.

Heliyon. 2018 Sep 22;4(9):e00804. doi: 10.1016/j.heliyon.2018.e00804. eCollection 2018 Sep.

32.

Correction to: Laparoscopic-assisted transversus abdominis plane block as an effective analgesic in total extraperitoneal inguinal hernia repair: a double-blind, randomized controlled trial.

Mughal A, Khan A, Rehman J, Naseem H, Riaz M, Waldron R, Duggan M, Khan W, Barry K, Khan IZ.

Hernia. 2018 Dec;22(6):1123. doi: 10.1007/s10029-018-1832-y.

PMID:
30242608
33.

Predictive physiological anticipatory activity preceding seemingly unpredictable stimuli: An update of Mossbridge et al's meta-analysis.

Duggan M, Tressoldi P.

Version 2. F1000Res. 2018 Mar 28 [revised 2018 Jan 1];7:407. doi: 10.12688/f1000research.14330.2. eCollection 2018.

34.

Laparoscopic-assisted transversus abdominis plane block as an effective analgesic in total extraperitoneal inguinal hernia repair: a double-blind, randomized controlled trial.

Mughal A, Khan A, Rehman J, Naseem H, Waldron R, Duggan M, Khan W, Barry K, Khan IZ.

Hernia. 2018 Oct;22(5):821-826. doi: 10.1007/s10029-018-1819-8. Epub 2018 Sep 1. Erratum in: Hernia. 2018 Sep 21;:.

35.

Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy.

Laws A, Anderson K, Hu J, McLean K, Novak L, Dominici LS, Nakhlis F, Carty M, Caterson S, Chun Y, Duggan M, Barry W, Connell N, Golshan M, King TA.

Ann Surg Oncol. 2018 Nov;25(12):3548-3555. doi: 10.1245/s10434-018-6696-y. Epub 2018 Aug 20.

PMID:
30128903
36.

PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer.

Pereira SP, Jitlal M, Duggan M, Lawrie E, Beare S, O'Donoghue P, Wasan HS, Valle JW, Bridgewater J.

ESMO Open. 2018 Jul 23;3(5):e000379. doi: 10.1136/esmoopen-2018-000379. eCollection 2018.

37.

Corrigendum to "Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179-5184].

Tarr JC, Wood MR, Noetzel MJ, Melancon BJ, Lamsal A, Luscombe VB, Rodriguez AL, Byers FW, Chang S, Cho HP, Engers DW, Jones CK, Niswender CM, Wood MW, Brandon NJ, Duggan ME, Conn PJ, Bridges TM, Lindsley CW.

Bioorg Med Chem Lett. 2018 Sep 15;28(17):3014. doi: 10.1016/j.bmcl.2018.07.022. Epub 2018 Jul 31. No abstract available.

38.

TAVR Versus SAVR in the Era of NSQIP.

Vadlamudi R, Duggan M.

J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2176-2177. doi: 10.1053/j.jvca.2018.05.037. Epub 2018 May 26. No abstract available.

PMID:
30054188
39.

Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.

Olaverria Salavaggione GN, Duggan MC, Carson WE.

Melanoma Res. 2018 Oct;28(5):390-397. doi: 10.1097/CMR.0000000000000474.

40.

The galanin receptor-3 antagonist, SNAP 37889, inhibits cue-induced reinstatement of alcohol-seeking and increases c-Fos expression in the nucleus accumbens shell of alcohol-preferring rats.

Wilson KE, Limburg S, Duggan MK, Lawther AJ, Williams SJ, Lawrence AJ, Hale MW, Djouma E.

J Psychopharmacol. 2018 Aug;32(8):911-921. doi: 10.1177/0269881118780015. Epub 2018 Jun 21.

PMID:
29926762
41.

Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.

Backen AC, Lopes A, Wasan H, Palmer DH, Duggan M, Cunningham D, Anthoney A, Corrie PG, Madhusudan S, Maraveyas A, Ross PJ, Waters JS, Steward WP, Rees C, McNamara MG, Beare S, Bridgewater JA, Dive C, Valle JW.

Br J Cancer. 2018 Jul;119(1):27-35. doi: 10.1038/s41416-018-0132-8. Epub 2018 Jun 21.

42.

Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.

Grossmith S, Nguyen A, Hu J, Plichta JK, Nakhlis F, Cutone L, Dominici L, Golshan M, Duggan M, Carter K, Rhei E, Barbie T, Calvillo K, Nimbkar S, Bellon J, Wong J, Punglia R, Barry W, King TA.

Ann Surg Oncol. 2018 Nov;25(12):3527-3534. doi: 10.1245/s10434-018-6525-3. Epub 2018 Jun 4.

PMID:
29868979
43.

Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.

Lai X, Stiff A, Duggan M, Wesolowski R, Carson WE 3rd, Friedman A.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5534-5539. doi: 10.1073/pnas.1721559115. Epub 2018 May 7.

44.

Atrioventricular Disruption After Aortic Valve Surgery: Early Detection by Intraoperative Echocardiography: A Case Report.

Sreeram G, Hyatt D, Fischer S, Thourani VH, Duggan M.

A A Pract. 2018 Jun 1;10(11):302-306. doi: 10.1213/XAA.0000000000000692.

PMID:
29634563
45.

Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity.

Johansson P, Kaspersson K, Gurrell IK, Bäck E, Eketjäll S, Scott CW, Cebers G, Thorne P, McKenzie MJ, Beaton H, Davey P, Kolmodin K, Holenz J, Duggan ME, Budd Haeberlein S, Bürli RW.

J Med Chem. 2018 Apr 26;61(8):3491-3502. doi: 10.1021/acs.jmedchem.7b01716. Epub 2018 Apr 10.

PMID:
29617572
46.

Diffuse optical monitoring of peripheral tissues during uncontrolled internal hemorrhage in a porcine model.

Vishwanath K, Gurjar R, Wolf D, Riccardi S, Duggan M, King D.

Biomed Opt Express. 2018 Jan 11;9(2):569-580. doi: 10.1364/BOE.9.000569. eCollection 2018 Feb 1.

47.

Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.

Sar A, Duan Q, Khalil M, DiFrancesco LM, Ewanowich C, Lytwyn A, Djordjevic B, Itani D, Lee S, Köbel M, Glaze S, Park E, Duggan MA.

J Low Genit Tract Dis. 2018 Apr;22(2):132-138. doi: 10.1097/LGT.0000000000000380.

PMID:
29474242
48.

Management of arthropod vector data - Social and ecological dynamics facing the One Health perspective.

Benelli G, Duggan MF.

Acta Trop. 2018 Jun;182:80-91. doi: 10.1016/j.actatropica.2018.02.015. Epub 2018 Feb 16. Review.

PMID:
29454734
49.

Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.

Samimi G, Trabert B, Duggan MA, Robinson JL, Coa KI, Waibel E, Garcia E, Minasian LM, Sherman ME.

Gynecol Oncol. 2018 Mar;148(3):515-520. doi: 10.1016/j.ygyno.2018.01.016.

50.

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.

Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace TA, Benner B, Kendra K, Campbell A, Gautam S, Abood D, Landi I, Hsu V, Duggan M, Wesolowski R, Old M, Howard JH, Yu L, Stasik N, Olencki T, Muthusamy N, Tridandapani S, Byrd JC, Caligiuri M, Carson WE.

Clin Cancer Res. 2018 Apr 15;24(8):1891-1904. doi: 10.1158/1078-0432.CCR-17-0691. Epub 2018 Jan 23.

Supplemental Content

Loading ...
Support Center